Hua-shan Shi
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Risk factors and prognosis of postoperative early relapse after neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a retrospective study.
Journal: World journal of surgical oncology
Published: May 27, 2025
Ferroptosis at the intersection of radiotherapy and immunotherapy.
Journal: Cancer metastasis reviews
Published: April 16, 2025
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.
Journal: Signal transduction and targeted therapy
Published: October 11, 2024
Different survival and recurrence patterns between neoadjuvant radiochemotherapy and immunochemotherapy in esophageal squamous cell carcinoma.
Journal: Current problems in surgery
Published: September 05, 2024
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial.
Journal: British journal of cancer
Published: April 29, 2024
The Promotion of Erythropoiesis via the Regulation of Reactive Oxygen Species by Lactic Acid.
Journal: Scientific reports
Published: December 01, 2015
Accumulation of FLT3(+) CD11c (+) dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor.
Journal: Immunologic research
Published: June 05, 2014
Ad-endostatin treatment combined with low-dose irradiation in a murine lung cancer model.
Journal: Oncology reports
Published: January 27, 2014
Inhibition of lymphatic metastases by a survivin dominant-negative mutant.
Journal: Oncology research
Published: October 22, 2013
Gene therapy with beta-defensin 2 induces antitumor immunity and enhances local antitumor effects.
Journal: Human gene therapy
Published: October 19, 2013
Last Updated: 09/26/2026